Our firm currently has a civil lawsuit in Alabama against Ethex Corporation and KV Pharmaceutical Company (KVP) involving the death of a person who took a prescription medication manufactured by Ethex. In February of this year, KVP, the parent company of Ethex, announced it had reached a settlement agreement, subject to court approval, with the United States Attorney for the Eastern District for Missouri and the Office of Consumer Litigation for the United States Department of Justice. This agreement – if approved – will resolve a criminal investigation regarding certain activities of Ethex Corporation.

Ethex Corporation is the generic pharmaceutical and distribution subsidiary of KVP.  Under the terms of this settlement, Ethex will plead guilty to criminal charges and will be required to pay a fine and restitution of $25.8 million.  Ethex also will not contest an administrative forfeiture of $1.8 million.  Ethex Corporation will plead guilty to two felony counts for failure in 2008 to file field alerts for the drugs Dextroamphetamine and Propafenone.

In light of the plea and likely exclusion of Ethex from participation in governmental programs, the company has elected to stop all operations of Ethex in the future.  It appears that KVP is stepping up to the plate and taking its medicine from the federal government in the criminal matters.  Our firm hopes to make them do the same thing in our civil case in Alabama.  If you have questions about this matter, you can contact Roger Smith, a lawyer in our firm, at Roger.Smith@beasleyallen.com or by phone at 800-898-2034.

Source: PR News Wire United Business Media